Page 1 of Clinical Trials for repeat dose, 2296 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH4808 After Oral Administration in Healthy Male Subjects
Last Updated: March 29, 2012
Condition(s): Healthy
2
Terminated
A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects
Last Updated: December 1, 2011
Condition(s): Hepatitis C
3
Completed
A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin
Last Updated: March 8, 2012
Condition(s): Autoimmune Diseases
4
Completed
A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers.
Last Updated: February 24, 2011
Condition(s): Sleep Disorders
5
Recruiting
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345.
Last Updated: May 10, 2012
Condition(s): Cough
6
Suspended
A Study to Evaluate Single and Repeat Doses of IV GSK2251052 in Healthy Male Japanese and Caucasian Subjects and Repeat Doses of Supratherapeutic Doses of IV GSK2251052 in Healthy Volunteers
Last Updated: February 23, 2012
Condition(s): Community-acquired Infection
7
Completed
Healthy Volunteer Study Using 3 Different Formulations of Firategrast
Last Updated: March 8, 2012
Condition(s): Multiple Sclerosis, Relapsing-Remitting
8
Not yet recruiting
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects
Last Updated: May 10, 2012
Condition(s): Infection, Human Immunodeficiency Virus
9
Completed
PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers
Last Updated: March 10, 2011
Condition(s): Alzheimer's Disease
10
Completed
A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.
Last Updated: March 8, 2012
Condition(s): Hepatitis C
11
Recruiting
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Last Updated: February 23, 2012
Condition(s): Drug Interactions; BRAF; Cancer
12
Completed
Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects
Last Updated: April 7, 2011
Condition(s): Healthy Subjects; Dyslipidaemias
13
Completed
A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects
Last Updated: January 27, 2011
Condition(s): Skin Diseases, Infectious; Pneumonia; Infections, Bacterial
14
Completed
GSK706769 Repeat Dose Study
Last Updated: March 30, 2012
Condition(s): Healthy Subjects; Infection, Human Immunodeficiency Virus
15
Completed
GSK1349572 Repeat Dose Escalation and Relative Bioavailability Study
Last Updated: October 14, 2010
Condition(s): Healthy Subjects
16
Completed
An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation.
Last Updated: October 20, 2011
Condition(s): Epilepsy
17
Completed
A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278
Last Updated: April 26, 2012
Condition(s): Huntingtons Disease
18
Terminated
A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat Malaria
Last Updated: February 16, 2012
Condition(s): Malaria
19
Completed
Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male Subjects
Last Updated: March 15, 2012
Condition(s): Allergic Rhinitis; Rhinitis, Allergic, Seasonal
20
Completed
Safety and Pharmacokinetics of Sialic Acid Tables in Patients With Hereditary Inclusion Body Myopathy (HIBM)
Last Updated: May 17, 2012
Condition(s): Hereditary Inclusion Body Myopathy (HIBM)

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=repeat+dose

Page 1 of Clinical Trials for repeat dose, 2296 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About